{"abortion induced": 41.81, "abortion spontaneous": 6.08, "acute hepatic failure": 10.52, "adverse event": 5.04, "alanine aminotransferase increased": 15.55, "ascites": 7.99, "aspartate aminotransferase increased": 3.91, "blood bilirubin increased": 6.26, "blood creatine phosphokinase increased": 10.22, "blood lactic acid increased": 21.58, "death": 4.86, "diabetes mellitus": 2.41, "drug ineffective": 4.39, "drug resistance": 72.46, "drug tolerance": 144.95, "dysphagia": 2.11, "exposure via body fluid": 449.91, "foetal exposure during pregnancy": 3.45, "haematuria": 2.05, "hepatic cancer": 119.92, "hepatic cirrhosis": 28.96, "hepatic encephalopathy": 19.33, "hepatic failure": 12.17, "hepatic function abnormal": 2.85, "hepatitis b": 84.81, "hepatitis b dna increased": 1189.24, "hepatitis b reactivation": 46.6, "hepatocellular carcinoma": 37.93, "hospitalisation": 4.7, "jaundice": 7.25, "lactic acidosis": 29.12, "lipase increased": 5.77, "liver disorder": 9.44, "lymphoma": 6.57, "maternal exposure during pregnancy": 5.39, "neoplasm malignant": 5.08, "no adverse event": 4.94, "paternal exposure timing unspecified": 207.75, "pregnancy": 25.28, "product quality issue": 4.05, "renal failure": 2.9, "renal impairment": 5.27, "rhabdomyolysis": 2.88, "surgery": 6.36, "suspected counterfeit product": 143.38, "therapeutic response decreased": 12.18, "transaminases increased": 7.01, "treatment noncompliance": 7.07, "viral load increased": 200.36, "virologic failure": 52.25}